Sign up to watch this video
Free access to all Sound Bites content
Dr. Hossein Borghaei describes the safety of nivo/ipi + chemo in patients with mNSCLC and the efficacy in patients who discontinue early. (Video 3/3)
Published on: October 23, 2025
Medical Professional
CM-9LA TRAEs
Related Videos
Dr. Charu Aggarwal discusses the efficacy of datopotamab deruxtecan in pretreated mNSCLC (Video 1/3)
Charu Aggarwal, MD
Dr. Eric Singhi reviews 5-year efficacy of cemiplimab + chemotherapy in aNSCLC (Video 1/3)
Eric Singhi , MD
Dr. Joshua Zeidner reviews the data for revumenib in patients with NPM1-mutated AML (Video 3/3)
Joshua Zeidner, MD
Dr. Hossein Borghaei describes the safety of nivo/ipi + chemo in patients with mNSCLC and the efficacy in patients who discontinue early. (Video 3/3)
Hossein Borghaei, MD
Dr. Arvind Dasari gives an overview of ctDNA with a focus on why the data from Galaxy and Bespoke-CRC was pooled for surveillance (Video 1/3)
Arvind Dasari, MD
Dr. Melissa Johnson describes the safety of atezolizumab + lurbinectedin maintenance therapy in 1L ES-SCLC. (Video 3/3)
Melissa Johnson
IDEOlogy Health Ranks No. 772 on the 2025 Inc. 5000 Fastest-Growing Private Companies in America
© 2025 IDEOlogy Health. All product names, logos, brands, trademarks and registered trademarks are property of their respective owners and their use(s) do not necessarily imply endorsement.